The government launched ‘Mission COVID Suraksha’, which will help the development process of approximately five to six Covid-19 vaccine candidates. Starting from the research and development part of the vaccines, the mission will help them in getting licence and will finally introduce them in the market. As several vaccines are in the final phase of trials, this mission will ensure that there is supply of enough doses of these vaccine shots, once they get approval. The government of india has announced the stimulus package of Rs. 900 crore for the Mission COVID Suraksha, the indian Covid-19 Vaccine Development Mission, which will help the development process of the vaccine candidates.
Amid allegations of vaccine shortages in the country, the ministry of science and technology has stated that the current production capacity of Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-Aug 2021. It is expected to reach nearly 10 crore doses per month by Sep 2021. The Ministry said that the government of india is providing financial assistance in the form of a grant of Rs 65 crore to Bharat Biotech's new Bangalore-based facility. 3 public sector companies are also collaborating to increase vaccine production capacity.
